Skip to main content
Sai Life Sciences Limited logo

Sai Life Sciences Limited — Investor Relations & Filings

Ticker · SAILIFE ISIN · INE570L01029 LEI · 335800JBS3NY25NIBC93 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 233 across all filing types
Latest filing 2025-11-14 Call Transcript
Country IN India
Listing BSE.NS SAILIFE

About Sai Life Sciences Limited

https://www.sailife.com

Sai Life Sciences Limited is a full-service Contract Research, Development, and Manufacturing Organization (CRO-CDMO) that partners with global pharmaceutical and biotechnology innovators to accelerate the discovery, development, and commercialization of complex small molecules. The company provides an integrated platform of services spanning discovery chemistry and biology, DMPK, toxicology, process development, analytical R&D, and commercial-scale manufacturing. With a focus on operational excellence and regulatory compliance, it operates state-of-the-art R&D and manufacturing facilities. Its value proposition centers on the Sai Nxt initiative, which emphasizes investments in advanced technologies, expanded capacity, and a global delivery model designed to reduce time-to-market for novel therapeutics.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is a letter addressed to stock exchanges (NSE and BSE) regarding the transcript of an earnings call for the unaudited financial results for the quarter and half year ended 30 September 2025. It explicitly states that the transcript of the earnings call is attached and also uploaded on the company's website. The document itself is short (1635 characters) and serves as a notification or submission of the transcript rather than the transcript content itself. According to the rules, a transcript of an earnings call is classified as a Call Transcript (CT). Since the document is about the transcript of the earnings call, the correct classification is CT with high confidence.
2025-11-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the rescheduling of a meeting with an analyst/investor. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document is an update on the schedule of investor meetings, not a financial report, earnings release, or presentation. It is a regulatory announcement related to investor relations and compliance with SEBI listing obligations. The document length is only 2174 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-11-13 English
Action(s) initiated or orders passed
Regulatory Filings Classification · 95% confidence The document is a disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It informs about an order passed by a tax authority regarding a GST demand and related penalties. The document is a formal announcement to stock exchanges providing details of the regulatory action and its potential impact on the company. It does not contain financial statements, audit results, or detailed management discussion. It is a regulatory announcement about a legal/tax matter, not a full report or financial filing. The document length is 3867 characters, relatively short and focused on disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-11-13 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about the schedule of meetings with analysts and investors. It explicitly states that no new presentation will be made and that no unpublished price sensitive information will be discussed. The document is an intimation or announcement of an upcoming investor meeting rather than a detailed investor presentation or financial report. It does not contain financial data, analysis, or detailed presentation materials. Given the nature and length of the document, it fits best under the category of Investor Presentation (IP) as it relates to investor communication, but since no actual presentation is included, it is more accurately a Regulatory Filing (RNS) as a general regulatory announcement about investor meetings under SEBI regulations.
2025-11-13 English
Monitoring Agency Report
Regulatory Filings Classification · 95% confidence The document is titled 'Monitoring Agency Report for the quarter ended on 30 September 2025 in relation to the Initial Public Offer (IPO) of the Company.' It is issued pursuant to SEBI regulations related to IPO proceeds monitoring. The content includes detailed information on the utilization of IPO proceeds, certifications by independent chartered accountants, and comments from the monitoring agency and the board of directors. The report is comprehensive, covering financial details and compliance with regulatory requirements for IPO proceeds. This type of document is a regulatory compliance report specifically monitoring IPO proceeds utilization, which is distinct from general financial reports or earnings releases. It is not an announcement or a brief notification but a full monitoring report. Therefore, the most appropriate classification is 'Regulatory Filings (RNS)' as it is a regulatory compliance report related to IPO monitoring, which does not fit into other specific categories like Annual Report or Earnings Release.
2025-11-12 English
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing a recruitment drive for 200 scientists by Sai Life Sciences. It is addressed to stock exchanges pursuant to SEBI Listing Regulations, indicating it is a regulatory announcement. The content focuses on hiring plans, expansion initiatives, and company background. There is no financial data, no discussion of financial results, no voting or shareholder meeting information, no audit or legal proceedings, and no mention of any report being attached or published. The document is not a report itself but a regulatory announcement about company operations and expansion. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-11-11 English

Browse filings by year

3 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.